Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 2000-2007

  Kim, Yong Man ^a   Kang, Hyung Sik ^a   Paik, Sang Gi ^b   Pyun, Kwang Ho ^a   Anderson, Karen L ^c   Torbett, Bruce E ^c   Choi, Inpyo ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERLEUKIN 18; PROTEIN PU.1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; INFLAMMATION; INTERFERON INDUCTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

5' UNTRANSLATED REGIONS; ANIMALS; BINDING SITES; CELL LINE; CONSENSUS SEQUENCE; DNA; GENE EXPRESSION REGULATION; INTERFERON REGULATORY FACTORS; INTERFERONS; INTERLEUKIN-18; LIPOPOLYSACCHARIDES; MICE; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SEQUENCE DELETION; TRANS-ACTIVATORS; TRANSFECTION;

EID: 0033567084     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Okamura, H., K. Nagata, T. Komatsu, T. Tanimoto, Y. Nukata, F. Tanabe, K. Akita, K. Torigoe, T. Okura, S. Fukuda, et al. 1995. A novel costimulatory factor for γ interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun. 63:3966.
2. Dinarello, C. A., D. Novick, A. J. Puren, G. Fantuzzi, and L. Shapiro. 1998. Overview of interleukin-18: more than an interferon-γ inducing factor. J. Leukocyte Biol. 63:658.
3. Okumara, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88.
4. Ushio, S., M. Namba, T. Okura, M. Hattori, Y. Nukada, K. Akita, F. Tanabe, K. Konoshi, M. Micallef, M. Fujii, et al. 1996. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activity of the protein. J. Immunol. 156:4274.
5. Gu, Y., K. Kuida, H. Tsutsui, G. Ku, K. Hsiao, M. A. Fleming, N. Hayashi, K. Higashino, H. Okamura, K. Nakanishi, et al. 1997. Activation of Interferon-γ inducing factor mediated by interleukin-1 β converting enzyme. Science 275:206.
6. Zhang, T., K. Kawakamo, M. Qureshi, H. Okamura, M. Kurimoto, and A. Saito. 1997. Interleukin-12 and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of γ interferon by natural killer cells. Infect. Immun. 65:3594.
7. Yoshimoto T., H. Okamura, Y.-I. Tagawa, Y. Iwakura, and K. Nakanishi. 1997. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc. Natl. Acad. Sci. USA 94:3948.
8. Torigoe, K., S. Ushio, T. Okura, S. Kobayashi, M. Taniai, T. Kunikata, T., Murakami, O. Sanou, H. Kojima, M. Fujii, et al. 1997. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272:25737.
9. Matsumoto S., K. Tsuji-Takayama, Y. Aizawa, K. Koide, M. Takeuchi, T. Ohta, and M. Kurimoto. 1997. Interleukin-18 activates NF-κB in murine T helper type 1 cells. Biochem. Biophys. Res. Commun. 234:454.
10. lck and MAPK in a murine TH1 clone. Biochem. Biophys. Res. Commun. 237:126.
11. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S. B. Hartley, S. Menon, R. Kastelein, F. Bazan, et al. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NF-κB. Immunity 7:571.
12. + human blood mononuclear cells. J. Clin. Invest. 101:711.
13. Tsutsui, H., K. Matsui, N. Kawada, Y. Hyodo, N. Hayashi, H. Okumura, K. Higashino, and K. Nakanishi. 1997. IL-18 accounts for both TNF-α and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J. Immunol. 159:3961.
14. Tsutsui, H., K. Nakanishi, K. Matsui, K. Higashino, H. Okamura, Y. Miyazawa, and K. Kaneda. 1996. IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157:3967.
15. Micallef, M. J., T. Tanimoto, K. Kohno, M. Ikeda, and M. Kurimoto. 1997. Interleukin-18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngenic mice from transplantation with Meth A sarcoma. Cancer Res. 57:4557.
16. Osaki, T., J.-M. Peron, Q. Cai, H. Okamura, P. Robbins, M. Kurimoto, M. T. Lotze, and H. Tahara. 1998. IFN-γ-inducing factor/IL-18 administration mediates IFN-γ-and IL-12-independent antitumor effects. J. Immunol. 160:1741.
17. Stoll, S., G. Mueller, M. Kurimoto, J. Saloga, T. Tanimoto, H. Yamauchi, H. Okamura, J. Knop, and A. H. Enk. 1997. Production of IL-18 (IFN-γ-inducing factor) messenger RNA and functional protein by murine keratinocytes. J. Immunol. 159:298.
18. Udagawa, N., N. J. Horwood, J. Elliott, A. Mackay, J. Owen, H. Okamura, M. Kurimoto, T. J. Chambers, T. J. Martin, and M. T. Gillespie. 1997. Interleukin-18 (IFN-γ-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-γ to inhibit osteoblast formation. J. Exp. Med. 185:1005.
19. Culhane, A. C., M. D. Hall, N. J. Rothwell, and G. N. Luheshi. 1998. Cloning of rat brain interleukin-18 cDNA. Mol. Psychol. 3:362.
20. Conti, B., J. W. Jahng, C. Tinti, J. H. Son, and T. H. Joh. 1997. Induction of interferon-γ inducing factor in the adrenal cortex. J. Biol. Chem. 272:2035.
21. Tone, M., S. A. J. Thompson, Y. Tone, P. J. Fairchild, and H. Waldmann. 1997. Regulation of IL-18 (IFN-γ-inducing factor) gene expression. J. Immunol. 159: 6156.
22. Anderson, K. L., K. A. Smith, F. Pio, B. E. Torbett, and R. A. Maki. 1998. Neutrophils deficient in PU.1 do not terminal differentiate or become functionally competent. Blood 92:1576.
23. Anderson, K. L., K. A. Smith, K. Conners, S. R. McKercher, R. A. Maki, and B. E. Torbett. 1998. Myeloid development is selectively disrupted in PU.1 null mice. Blood 91:3702.
24. Gorman, C. M., L. F. Moffat, and B, H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044.
25. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1474.
26. Driggers, P. H., D. L. Ennist, S. L. Gleason, W. H. Mak, M. S. Marks, B.-Z. Levi, J. R. Flanagan, E. Appella, and K. Ozato. 1990. An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. USA 87:3743.
27. Tanaka, N., T. Kawakami, and T. Taniguchi. 1993. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13:4531.
28. Weisz, A., P. Marx, R. Sharf, E. Appella, P. H. Driggers, K. Ozato, and B.-Z. Levi. 1992. Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J. Biol. Chem. 267:25589.
29. Novick, D., S.-H. Kirn, G. Fantuzzi, L. L. Reznikov, C. A. Dinarello, and M. Rubinstein. 1999. Interleukin-18 binding protein: a novel modulator of Th1 cytokine response. Immunity 10:127.
30. phox expression. J. Biol. Chem. 273:13957.
31. Lodie, T. A., R. Savedra, Jr., D. T. Golenbock, C. P. van Beveren, R. A. Maki, and M. J. Fenton. 1997. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J. Immunol. 158:1848.
32. Shackelford, R., D. O. Adams, and S. P. Johnson. 1995. IFN-γ and lipopolysaccharide induce DNA binding of transcription factor PU.1 in murine tissue macrophages. J. Immunol. 154:1374.
33. Wu, C.-Y., H. Maeda, C. Contursi, K. Ozato, and R. A. Seder. 1999. Differential requirement of IFN consensus sequence binding protein for the production of IL-12 and induction of Th1-type cells in response to IFN-γ. J. Immunol. 162:807.
34. Scharton-Kersten, T., C. Contursi, A. Masumi, A. Sher, and K. Ozato. 1997. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J. Exp. Med. 186:1523.
35. Shart, R., A. Azriel, F. Lejbkowicz, S. Winograde, R. Ehrlich, and B.-Z. Levi. 1995. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J. Biol. Chem. 270:13063.
36. Sharf, R., D. Merara, A. Azriel, A. M. Thornton, K. Ozato, E. F. Petricoin, A. C. Larner, F. Schaper, H. Hauser, and B.-Z. Levi. 1997. Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J. Biol. Chem. 272: 9785.
37. Brass, A. L., E. Kehrli, C. F. Eisenbeis, U. Storb, and H. Singh. 1996. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the ets factor PU.1. Genes Dev. 10:2335.